SIMULATIONS PLUS INC (SLP) Stock Fundamental Analysis
USA - NASDAQ:SLP - US8292141053 - Common Stock
15.43 USD
0 (0%)
15.43 USD
0 (0%)
SLP gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. SLP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. SLP shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
SLP had positive earnings in the past year.
SLP had a positive operating cash flow in the past year.
SLP had positive earnings in each of the past 5 years.
Each year in the past 5 years SLP had a positive operating cash flow.
1.2 Ratios
SLP has a Return On Assets of -47.03%. This is in the lower half of the industry: SLP underperforms 77.14% of its industry peers.
Looking at the Return On Equity, with a value of -51.05%, SLP is in line with its industry, outperforming 45.71% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 3.12%, SLP is in the better half of the industry, outperforming 77.14% of the companies in the same industry.
SLP had an Average Return On Invested Capital over the past 3 years of 4.57%. This is below the industry average of 6.80%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -47.03% | ||
| ROE | -51.05% | ||
| ROIC | 3.12% |
ROA(3y)5.68%
ROA(5y)5.6%
ROE(3y)6.11%
ROE(5y)6.04%
ROIC(3y)4.57%
ROIC(5y)5.03%
1.3 Margins
SLP's Profit Margin has declined in the last couple of years.
SLP's Operating Margin of 5.82% is fine compared to the rest of the industry. SLP outperforms 71.43% of its industry peers.
SLP's Operating Margin has declined in the last couple of years.
The Gross Margin of SLP (53.75%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of SLP has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.82% | ||
| PM (TTM) | N/A | ||
| GM | 53.75% |
OM growth 3Y-28.77%
OM growth 5Y-22.51%
PM growth 3Y-12.26%
PM growth 5Y-10.86%
GM growth 3Y-7.23%
GM growth 5Y-3.44%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SLP is destroying value.
The number of shares outstanding for SLP has been increased compared to 1 year ago.
SLP has more shares outstanding than it did 5 years ago.
SLP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 18.35 indicates that SLP is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 18.35, SLP belongs to the top of the industry, outperforming 91.43% of the companies in the same industry.
There is no outstanding debt for SLP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 18.35 |
ROIC/WACC0.33
WACC9.44%
2.3 Liquidity
A Current Ratio of 5.11 indicates that SLP has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.11, SLP belongs to the top of the industry, outperforming 88.57% of the companies in the same industry.
A Quick Ratio of 5.11 indicates that SLP has no problem at all paying its short term obligations.
SLP's Quick ratio of 5.11 is amongst the best of the industry. SLP outperforms 88.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.11 | ||
| Quick Ratio | 5.11 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 38.30% over the past year.
SLP shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.41% yearly.
SLP shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.01%.
The Revenue has been growing by 15.56% on average over the past years. This is quite good.
EPS 1Y (TTM)38.3%
EPS 3Y2.13%
EPS 5Y0.41%
EPS Q2Q%200%
Revenue 1Y (TTM)20.01%
Revenue growth 3Y14.64%
Revenue growth 5Y15.56%
Sales Q2Q%9.81%
3.2 Future
The Earnings Per Share is expected to grow by 36.75% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.83% on average over the next years. This is quite good.
EPS Next Y-567.9%
EPS Next 2Y-7.23%
EPS Next 3Y6.04%
EPS Next 5Y36.75%
Revenue Next Year10.03%
Revenue Next 2Y6.49%
Revenue Next 3Y6.43%
Revenue Next 5Y11.83%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 23.74, SLP is valued on the expensive side.
Based on the Price/Earnings ratio, SLP is valued cheaper than 88.57% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.20. SLP is around the same levels.
The Price/Forward Earnings ratio is 36.59, which means the current valuation is very expensive for SLP.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SLP indicates a somewhat cheap valuation: SLP is cheaper than 65.71% of the companies listed in the same industry.
SLP's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.70.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.74 | ||
| Fwd PE | 36.59 |
4.2 Price Multiples
71.43% of the companies in the same industry are more expensive than SLP, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, SLP is valued a bit cheaper than 74.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.45 | ||
| EV/EBITDA | 20.42 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)57.45
EPS Next 2Y-7.23%
EPS Next 3Y6.04%
5. Dividend
5.1 Amount
No dividends for SLP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
15.43
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners81.06%
Inst Owner Change0.76%
Ins Owners17.32%
Ins Owner Change-1.84%
Market Cap310.61M
Analysts82
Price Target25.84 (67.47%)
Short Float %9.73%
Short Ratio2.39
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.24
Dividend Growth(5Y)0.01%
DP-1.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)160.9%
Min EPS beat(2)0.69%
Max EPS beat(2)321.12%
EPS beat(4)2
Avg EPS beat(4)55.29%
Min EPS beat(4)-90.66%
Max EPS beat(4)321.12%
EPS beat(8)3
Avg EPS beat(8)16.77%
EPS beat(12)4
Avg EPS beat(12)5.67%
EPS beat(16)7
Avg EPS beat(16)7.48%
Revenue beat(2)2
Avg Revenue beat(2)0.96%
Min Revenue beat(2)0.63%
Max Revenue beat(2)1.3%
Revenue beat(4)2
Avg Revenue beat(4)-1.21%
Min Revenue beat(4)-6.39%
Max Revenue beat(4)1.3%
Revenue beat(8)5
Avg Revenue beat(8)-0.3%
Revenue beat(12)6
Avg Revenue beat(12)-0.44%
Revenue beat(16)10
Avg Revenue beat(16)1.72%
PT rev (1m)0%
PT rev (3m)-39.68%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-121.68%
EPS NY rev (1m)-842.44%
EPS NY rev (3m)-496.39%
Revenue NQ rev (1m)-7.78%
Revenue NQ rev (3m)-37.01%
Revenue NY rev (1m)-2.2%
Revenue NY rev (3m)-13.41%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.74 | ||
| Fwd PE | 36.59 | ||
| P/S | 3.86 | ||
| P/FCF | 29.45 | ||
| P/OCF | 21.87 | ||
| P/B | 2.51 | ||
| P/tB | 6.19 | ||
| EV/EBITDA | 20.42 |
EPS(TTM)0.65
EY4.21%
EPS(NY)0.42
Fwd EY2.73%
FCF(TTM)0.52
FCFY3.4%
OCF(TTM)0.71
OCFY4.57%
SpS3.99
BVpS6.15
TBVpS2.49
PEG (NY)N/A
PEG (5Y)57.45
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -47.03% | ||
| ROE | -51.05% | ||
| ROCE | 3.77% | ||
| ROIC | 3.12% | ||
| ROICexc | 4.04% | ||
| ROICexgc | 17.48% | ||
| OM | 5.82% | ||
| PM (TTM) | N/A | ||
| GM | 53.75% | ||
| FCFM | 13.12% |
ROA(3y)5.68%
ROA(5y)5.6%
ROE(3y)6.11%
ROE(5y)6.04%
ROIC(3y)4.57%
ROIC(5y)5.03%
ROICexc(3y)12.97%
ROICexc(5y)16.03%
ROICexgc(3y)84.29%
ROICexgc(5y)97.41%
ROCE(3y)5.53%
ROCE(5y)6.08%
ROICexcg growth 3Y-24.94%
ROICexcg growth 5Y-20.15%
ROICexc growth 3Y-47.05%
ROICexc growth 5Y-36.7%
OM growth 3Y-28.77%
OM growth 5Y-22.51%
PM growth 3Y-12.26%
PM growth 5Y-10.86%
GM growth 3Y-7.23%
GM growth 5Y-3.44%
F-Score4
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 40.33% | ||
| Cap/Sales | 4.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 103.33% | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.11 | ||
| Quick Ratio | 5.11 | ||
| Altman-Z | 18.35 |
F-Score4
WACC9.44%
ROIC/WACC0.33
Cap/Depr(3y)99.44%
Cap/Depr(5y)102.61%
Cap/Sales(3y)6.89%
Cap/Sales(5y)7.35%
Profit Quality(3y)126.28%
Profit Quality(5y)123.52%
High Growth Momentum
Growth
EPS 1Y (TTM)38.3%
EPS 3Y2.13%
EPS 5Y0.41%
EPS Q2Q%200%
EPS Next Y-567.9%
EPS Next 2Y-7.23%
EPS Next 3Y6.04%
EPS Next 5Y36.75%
Revenue 1Y (TTM)20.01%
Revenue growth 3Y14.64%
Revenue growth 5Y15.56%
Sales Q2Q%9.81%
Revenue Next Year10.03%
Revenue Next 2Y6.49%
Revenue Next 3Y6.43%
Revenue Next 5Y11.83%
EBIT growth 1Y-33.13%
EBIT growth 3Y-18.34%
EBIT growth 5Y-10.46%
EBIT Next Year145.07%
EBIT Next 3Y49.49%
EBIT Next 5Y49.82%
FCF growth 1Y-52.99%
FCF growth 3Y-14.87%
FCF growth 5Y-1.4%
OCF growth 1Y-46.86%
OCF growth 3Y-11.47%
OCF growth 5Y2.73%